Rabbit Anti-E2F6 Recombinant Antibody (E0682) (V2LY-0425-LY1251)

Liu, Y., Yao, Y., Liao, B., Zhang, H., Yang, Z., Xia, P., ... & Yuan, Y. (2022). A positive feedback loop of CENPU/E2F6/E2F1 facilitates proliferation and metastasis via ubiquitination of E2F6 in hepatocellular carcinoma. International journal of biological sciences, 18(10), 4071-4087.

Chen, G., Wang, K., Li, G., Wang, L., Xiao, Y., & Chen, B. (2022). Long noncoding RNA LAMTOR5-AS1 interference affects microRNA-506-3p/E2F6-mediated behavior of non-small cell lung cancer cells. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, 28(9), 945-959.

Gu, Q., Hou, W., Shi, L., Liu, H., Zhu, Z., & Ye, W. (2021). Circular RNA ZNF609 functions as a competing endogenous RNA in regulating E2F transcription factor 6 through competitively binding to microRNA-197-3p to promote the progression of cervical cancer progression. Bioengineered, 12(1), 927-936.

Li, J., Li, D., Zhang, X., Li, C., & Zhu, F. (2021). Long noncoding RNA SLC9A3‑AS1 increases E2F6 expression by sponging microRNA‑486‑5p and thus facilitates the oncogenesis of nasopharyngeal carcinoma. Oncology Reports, 46(2), 1-13.

LAFTA, I. (2019). E2F6 is essential for cell viability in breast cancer cells during replication stress. Turkish Journal of Biology, 43(5), 293-304.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols